Full-Time

Strategic Project Manager

Posted on 5/11/2026

Deadline 5/16/26
LabCorp

LabCorp

10,001+ employees

Global life sciences R&D services

No salary listed

Indianapolis, IN, USA

In Person

Category
Business & Strategy (1)
Required Skills
Power BI
Risk Management
Data Analysis
Requirements
  • Master’s degree in Life Science, Project Management, or IT
  • PMP certification
  • 5 or more years’ experience of full-time Project Management
  • Proven experience managing end-to-end IT or operational projects, including initiation, planning, execution, monitoring, and closure
  • Demonstrated success leading complex, global, and cross-functional strategic projects within regulated or laboratory environments
  • Experience working within a Project Management Office (PMO) structure, with strong adherence to governance, reporting, and changing control processes
  • Proficiency with project management tools (e.g., Microsoft Project) and the Microsoft Office suite
  • Experience leveraging data analytics and visualization tools (e.g., Power BI) to support project tracking, reporting, and decision-making
  • History of delivering projects on time, within scope, and on or under budget
  • Experience managing project financials, resource planning, and utilization forecasting
  • Background working in a global, multicultural environment with geographically dispersed teams
  • Experience driving continuous improvement and operational efficiency initiatives
  • Strong leadership skills with the ability to motivate cross-functional teams and align stakeholders to a shared project vision
  • Demonstrated ability to influence, negotiate, and manage stakeholder relationships, including senior leadership and external clients
  • Excellent communication skills, with the ability to deliver clear, concise updates through reports, presentations, and meetings
  • Strong customer focus, ensuring internal and external client requirements and expectations are consistently met
  • Effective problem-solving and conflict resolution skills, with the ability to manage project risks and issues proactively
  • Highly organized with strong planning, prioritization, and critical-thinking capabilities
  • Self-driven with a high degree of initiative and the ability to work both independently and collaboratively
  • Proven ability to operate effectively in complex, fast-paced, and matrixed environments
Responsibilities
  • Manages the day-to-day operational and tactical aspects of projects assigned
  • Creates and manages detailed project plans
  • Reports project status to team, management and stakeholders through regular status reports, management reports, and communications meetings
  • Tracks project issues and ensures appropriate resolution working closely with the upper leadership
  • Holds formal project reviews with management to ensure successful project execution and customer satisfaction
  • Delivers projects successfully on time and on or under budget with regularity and predictability
  • Records actual labor utilization on the project and creates resource utilization forecasts
  • Assists the laboratory management and the wider organization in the following aspects of project planning: project scope and change control processes; project status updates; project’s budget allocation, approval, and management
  • Employs effective general management and people skills
  • Manages the relationship within project teams, executive sponsors, and all identified stakeholders
  • Motivates teams by presenting a vision and strategy for delivery
  • Negotiate on behalf of all project team members to ensure service delivery and team satisfaction
  • Effectively work with a diverse group of stakeholders in the organization
  • Communicates effectively with all levels of staff and management

Labcorp provides end-to-end R&D services for life sciences and agricultural clients, including crop protection, with testing and regulatory support. It runs physicochemical analyses, safety assessments, and inhalation toxicology studies using specialized labs to evaluate inhaled substances. It differentiates itself with a global footprint and an integrated set of services across the product lifecycle, including regulatory submissions. Its goal is to help clients bring safe, effective products to market efficiently by applying rigorous science and scalable testing.

Company Size

10,001+

Company Stage

IPO

Headquarters

Burlington, Vermont

Founded

1976

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue hit $3.54B, up 5.8%, raising full-year guidance to $14.73B.
  • AI Alzheimer's platform validates spring 2026, expands to oncology and cardiometabolic areas.
  • Optum.ai partnership automates lab workflows and enhances patient engagement.

What critics are saying

  • Quest Diagnostics outgrows Labcorp at 9.2% versus 5.8%, eroding diagnostics share in 6-12 months.
  • NeoGenomics seizes oncology volume with 11.1% growth, hitting Labcorp's specialty testing now.
  • Tempus commoditizes Labcorp's AI platform with superior EHR integration in 24 months.

What makes LabCorp unique

  • Labcorp's AI platform with AWS and Datavant analyzes Alzheimer's data in minutes using deidentified lab datasets.
  • Labcorp holds first FDA clearance for rapid fentanyl urine test in emergency settings.
  • Labcorp's Plasma Detect Genome MRD assesses NSCLC recurrence risk via whole-genome sequencing.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at LabCorp who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Unlimited Paid Time Off

Tuition Reimbursement

Employee Stock Purchase Plan

Company News

360Dx
May 5th, 2026
Fox Chase Cancer Center, Labcorp collaborate on clinical trial for Plasma Detect Genome MRD in NSCLC.

Fox Chase Cancer Center, Labcorp collaborate on clinical trial for Plasma Detect Genome MRD in NSCLC. NEW YORK - Temple Health's Fox Chase Cancer Center and Laboratory Corporation of America announced Tuesday a clinical trial collaboration to evaluate the use of Labcorp's whole-genome sequencing Plasma Detect Genome MRD to assess the risk of recurrence in patients with early stage non-small cell lung cancer (NSCLC). Get the full story with 360dx Premium. Only $95 for the first 90 days. Full site access Interest-based email alerts Premium Access - Trial Offer $95.00 for 3 month

Resonate Group
Apr 15th, 2026
Labcorp launches rapid fentanyl test with 48-hour detection window.

Labcorp launches rapid fentanyl test with 48-hour detection window. * April 15, 2026 While fentanyl overdose deaths have been falling in recent years, use of the drug remains a major public health crisis in the U.S., and now Labcorp is launching a new test designed to detect the drug's use for up to 48 hours after exposure. Fields (*) Mark are Required

PR Newswire
Apr 14th, 2026
Labcorp launches AI-powered platform with AWS and Datavant to accelerate Alzheimer's research

Labcorp has launched an AI-powered real-world data platform to accelerate Alzheimer's disease research, developed in collaboration with Amazon Web Services and Datavant. The platform aims to generate insights in minutes that previously required months of data analysis. The system combines Labcorp's diagnostic and genomic datasets with medical claims data, using AWS AI services including Amazon Bedrock and Amazon SageMaker. It enables researchers to identify patient cohorts, track disease progression and measure treatment effectiveness across diverse populations using deidentified healthcare data. With over 7.2 million Americans living with Alzheimer's and annual care costs exceeding $380 billion in the US, the platform addresses traditional challenges of fragmented data and lengthy preparation times. Initial validation will complete in spring 2026, with plans to expand into inflammatory diseases, cardiometabolic conditions, women's health and oncology.

360Dx
Apr 13th, 2026
Labcorp, CHOP to develop, commercialize specialty pediatric diagnostics.

Labcorp, CHOP to develop, commercialize specialty pediatric diagnostics. NEW YORK - Laboratory Corporation of America and Children's Hospital of Philadelphia (CHOP) on Monday announced a strategic collaboration to accelerate the development of and access to specialized pediatric diagnostics. Get the full story with 360dx Premium. Only $95 for the first 90 days. Full site access Interest-based email alerts Premium Access - Trial Offer $95.00 for 3 month

360Dx
Mar 20th, 2026
In brief this week: Labcorp, guardant Health, waters, fulgent genetics, more.

In brief this week: Labcorp, guardant Health, waters, fulgent genetics, more. NEW YORK - Laboratory Corporation of America this week said it has completed its acquisition of select assets of Crouse Health's Laboratory Alliance of Central New York's laboratory business. The two firms also have entered into a deal for Crouse Health to manage the daily operations of its inpatient lab, while Labcorp will take over operations of the lab alliance's 12 patient service centers. It said in a statement that the deal will improve access to high-quality, affordable diagnostic services in Central New York by offering patients and providers Labcorp's expanded testing menu, data, and digital tools. To read the full story... What's Popular?